Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2013, Article ID 793927, 6 pages
http://dx.doi.org/10.1155/2013/793927
Case Report

PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical Problems

1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University at Dresden, Fetscherstraße 74, 01307 Dresden, Germany
2Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University at Dresden, 01307 Dresden, Germany
3Department of Radiology, University Hospital Carl Gustav Carus, Technical University at Dresden, 01307 Dresden, Germany
4PET Center, Institute of Radiopharmacy, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany
5Interdisciplinary Oncology, HELIOS Klinikum Berlin-Buch, 13125 Berlin, Germany

Received 24 May 2013; Accepted 12 June 2013

Academic Editors: S. B. Chichareon, G. P. Vandoros, Y. Yokoyama, and N. Yoshimura

Copyright © 2013 Markus K. Schuler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) is a new whole-body hybrid PET/MR imaging technique that combines metabolic and cross-sectional diagnostic imaging. Since the use of MRI in imaging of soft-tissue sarcoma is extremely beneficial, investigation of the combined PET/MRI is of great interest. In this paper, we present three cases and first data. Combined PET/MRI technique can support the process of clinical decision-making and give answers to some meaningful questions when treating patients with STS. Therefore, the combined modality of simultaneous PET/MRI offers new pieces to the puzzle of sarcoma treatment.